Literature DB >> 9115225

Flunitrazepam has an inverse agonistic effect on recombinant alpha6beta2gamma2-GABAA receptors via a flunitrazepam-binding site.

C A Hauser1, C H Wetzel, B Berning, F M Gerner, R Rupprecht.   

Abstract

gamma-Aminobutyric acid type A (GABAA) receptor subtypes containing the alpha6-subunit are generally thought to be insensitive to the action of benzodiazepine agonists. We describe the specific binding of the benzodiazepine agonist flunitrazepam to alpha6beta2gamma2-containing GABAA receptors, which has not been observed before and differs from previous reports. With the whole-cell voltage-clamp technique, we observed a functional discrimination between alpha1beta2gamma2- and alpha6beta2gamma2-receptors. Different benzodiazepines had different effects on GABA-evoked chloride currents. The agonist flunitrazepam had an inverse agonistic effect, whereas the antagonist flumazenil increased GABA-induced chloride currents. The action of flunitrazepam on the channel activity of alpha6beta2gamma2-receptors was opposite to its action on alpha1beta2gamma2-receptors. We conclude that flunitrazepam can act as either an agonist or an inverse agonist, depending on the GABAA receptor configuration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9115225     DOI: 10.1074/jbc.272.18.11723

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  A novel GABA(A) receptor pharmacology: drugs interacting with the α(+) β(-) interface.

Authors:  Werner Sieghart; Joachim Ramerstorfer; Isabella Sarto-Jackson; Zdravko Varagic; Margot Ernst
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Development of Inhaled GABAA Receptor Modulators to Improve Airway Function in Bronchoconstrictive Disorders.

Authors:  Nicolas M Zahn; M S Rashid Roni; Gene T Yocum; Michelle J Meyer; Daniel A Webb; Md Yeunus Mian; James M Cook; Douglas C Stafford; Charles W Emala; Leggy A Arnold
Journal:  ACS Pharmacol Transl Sci       Date:  2022-02-01

3.  Comparative pharmacodynamic and pharmacokinetic study of MIDD0301 and its (S) enantiomer.

Authors:  M S Rashid Roni; Nicolas M Zahn; Gene T Yocum; Daniel A Webb; Md Yeunus Mian; Michelle J Meyer; Anika S Tylek; James M Cook; Charles W Emala; Douglas C Stafford; Leggy A Arnold
Journal:  Drug Dev Res       Date:  2022-03-04       Impact factor: 5.004

Review 4.  [Significance of GABAA receptors for the pathophysiology and therapy of panic disorders].

Authors:  R Rupprecht; P Zwanzger
Journal:  Nervenarzt       Date:  2003-06-24       Impact factor: 1.214

5.  Pharmacological plasticity of GABA(A) receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy.

Authors:  Claire Leroy; Pierrick Poisbeau; A Florence Keller; Astrid Nehlig
Journal:  J Physiol       Date:  2004-03-19       Impact factor: 5.182

6.  The GABAA receptor alpha+beta- interface: a novel target for subtype selective drugs.

Authors:  Joachim Ramerstorfer; Roman Furtmüller; Isabella Sarto-Jackson; Zdravko Varagic; Werner Sieghart; Margot Ernst
Journal:  J Neurosci       Date:  2011-01-19       Impact factor: 6.167

7.  Cryo-EM structure of the benzodiazepine-sensitive α1β1γ2S tri-heteromeric GABAA receptor in complex with GABA.

Authors:  Swastik Phulera; Hongtao Zhu; Jie Yu; Derek P Claxton; Nate Yoder; Craig Yoshioka; Eric Gouaux
Journal:  Elife       Date:  2018-07-25       Impact factor: 8.140

8.  The Importance of L-Arginine:NO:cGMP Pathway in Tolerance to Flunitrazepam in Mice.

Authors:  Sylwia Talarek; Joanna Listos; Jolanta Orzelska-Gorka; Malgorzata Jakobczuk; Jolanta Kotlinska; Grazyna Biala
Journal:  Neurotox Res       Date:  2016-12-12       Impact factor: 3.911

9.  A Structure-Activity Relationship Comparison of Imidazodiazepines Binding at Kappa, Mu, and Delta Opioid Receptors and the GABAA Receptor.

Authors:  Guanguan Li; Amanda N Nieman; Md Yeunus Mian; Nicolas M Zahn; Brandon N Mikulsky; Michael M Poe; Kashi R Methuku; Yongfeng Liu; James M Cook; Douglas C Stafford; Leggy A Arnold
Journal:  Molecules       Date:  2020-08-25       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.